NLRP3 and Alzheimer disease: Furthermore, He et al. found that Oridonin inhibits activation of the NLRP3 inflammasome through binding with the NLRP3 NACHT domain to block NLRP3-NEK7 interactions, suggesting that Oridonin might be a promising treatment agent for AD-related neuroinflammation [86].